Clinical Trial Detail

NCT ID NCT03760523
Title Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

acute myeloid leukemia

Therapies

Minnelide

Age Groups: adult senior

No variant requirements are available.